Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Highly frequent undesired insertional mutagenesis during Drosophila genome editing.

PLoS genetics·2026
Same author

Restoring the interplay between the endoplasmic reticulum and mitochondria by gene therapy improves Charcot-Marie-Tooth type 2A disease.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Reactive species generated by a cold atmospheric plasma inactivate AAV through oxidative and nitrosative stress.

Scientific reports·2026
Same author

TMEM145 is a principal component of outer hair cell stereocilia.

Neuron·2026
Same author

Evolutionary tuning of an auditory transduction channel.

Current biology : CB·2026
Same author

Mifepristone alone and in combination with scAAV9-SMN1 gene therapy improves disease phenotypes in Smn<sup>2B/-</sup> spinal muscular atrophy mice.

Scientific reports·2025

Related Experiment Video

Updated: Apr 7, 2026

Surgical Method for Virally Mediated Gene Delivery to the Mouse Inner Ear through the Round Window Membrane
07:32

Surgical Method for Virally Mediated Gene Delivery to the Mouse Inner Ear through the Round Window Membrane

Published on: March 16, 2015

17.5K

Tmc gene therapy restores auditory function in deaf mice.

Charles Askew1, Cylia Rochat2, Bifeng Pan3

  • 1Department of Otolaryngology, F.M. Kirby Neurobiology Center, Boston Children's Hospital and Harvard Medical School, Boston, MA 02115, USA. Neuroscience Graduate Program, University of Virginia, Charlottesville, VA 22908, USA.

Science Translational Medicine
|July 10, 2015
PubMed
Summary

Gene therapy using adeno-associated virus (AAV) successfully restored hearing in mouse models of genetic deafness. This approach shows promise for treating inherited hearing loss caused by TMC1 mutations.

More Related Videos

Posterior Semicircular Canal Approach for Inner Ear Gene Delivery in Neonatal Mouse
03:52

Posterior Semicircular Canal Approach for Inner Ear Gene Delivery in Neonatal Mouse

Published on: March 2, 2018

11.1K
Canalostomy As a Surgical Approach to Local Drug Delivery into the Inner Ears of Adult and Neonatal Mice
09:34

Canalostomy As a Surgical Approach to Local Drug Delivery into the Inner Ears of Adult and Neonatal Mice

Published on: May 25, 2018

11.9K

Related Experiment Videos

Last Updated: Apr 7, 2026

Surgical Method for Virally Mediated Gene Delivery to the Mouse Inner Ear through the Round Window Membrane
07:32

Surgical Method for Virally Mediated Gene Delivery to the Mouse Inner Ear through the Round Window Membrane

Published on: March 16, 2015

17.5K
Posterior Semicircular Canal Approach for Inner Ear Gene Delivery in Neonatal Mouse
03:52

Posterior Semicircular Canal Approach for Inner Ear Gene Delivery in Neonatal Mouse

Published on: March 2, 2018

11.1K
Canalostomy As a Surgical Approach to Local Drug Delivery into the Inner Ears of Adult and Neonatal Mice
09:34

Canalostomy As a Surgical Approach to Local Drug Delivery into the Inner Ears of Adult and Neonatal Mice

Published on: May 25, 2018

11.9K

Area of Science:

  • Otolaryngology
  • Genetics
  • Molecular Biology

Background:

  • Genetic hearing loss is a significant cause of prelingual deafness globally.
  • Current treatments for genetic hearing loss are limited, with no biologic options available.
  • Mutations in the transmembrane channel-like 1 (TMC1) gene cause DFNB7/11 and DFNA36 forms of inherited deafness.

Purpose of the Study:

  • To evaluate gene therapy as a potential biologic treatment for genetic hearing loss.
  • To investigate the efficacy of gene augmentation using TMC1 in mouse models of deafness.
  • To identify optimal adeno-associated viral (AAV) vectors and promoters for inner ear gene delivery.

Main Methods:

  • Utilized mouse models with targeted Tmc1 deletion or the Beethoven point mutation.
  • Screened various AAV serotypes and promoters for efficient Tmc1 expression in inner hair cells.
  • Administered exogenous Tmc1 or Tmc2 via AAV2/1 with the chicken β-actin (Cba) promoter.

Main Results:

  • Identified AAV2/1 and the Cba promoter as an effective combination for in vivo Tmc1 expression.
  • Restored sensory transduction and auditory function, including auditory brainstem responses and acoustic startle reflexes, in deaf mice.
  • Demonstrated that exogenous Tmc1 or Tmc2 can compensate for the loss of functional Tmc1.

Conclusions:

  • Gene augmentation with Tmc1 or Tmc2 is a viable strategy for treating TMC1-related genetic hearing loss.
  • This gene therapy approach holds potential for clinical development in patients with inherited deafness.
  • Further research is warranted to advance this gene therapy for human application.